Objective-Abdominal aortic aneurysm (AAA) is widespread among elderly people and results in progressive expansion and rupture of the aorta with high mortality. Macrophages, which are the main population observed within the site of aneurysm, are thought to derive from circulating monocytes although no direct evidence has been provided to date. In this study, we were particularly interested in understanding the trafficking behavior of monocyte subsets in AAA and their role in disease pathogenesis. Approach and Results-Using bone marrow transplantation in Apoe −/− mice, we showed that circulating monocytes give rise to abdominal aortic macrophages in hypercholesterolemic mice submitted to angiotensin II (AngII). Detailed monitoring of monocyte compartmentalization revealed that lymphocyte antigen 6C high and lymphocyte antigen 6C low monocytes transiently increase in blood early after AngII infusion and differentially infiltrate the abdominal aorta. The splenic reservoir accounted for the mobilization of the 2 monocyte subsets after 3 days of AngII infusion. Spleen removal or lymphocyte deficiency in Apoe −/− Rag2 −/− mice similarly impaired early monocyte increase in blood in response to AngII and protected against AAA development, independently of blood pressure. Reconstitution of Apoe −/− Rag2 −/− mice with total splenocytes but not with B-cell-depleted splenocytes restored monocyte mobilization in response to AngII and enhanced susceptibility to AAA. Conclusions-Taken together, the data show that lymphocyte antigen 6C high and lymphocyte antigen 6C low monocytes are mobilized from the spleen in response to AngII. Intriguingly, the process is dependent on the presence of B cells and significantly contributes to the development of AAA and the occurrence of aortic rupture. (Arterioscler Thromb Vasc Biol. 2015;35:378-388. The online-only Data Supplement is available with this article at http://atvb.ahajournals.org/lookup/suppl/
A bdominal aortic aneurysm (AAA) is a common vascular disease of the abdominal aorta, characterized by medial degeneration and various degrees of chronic aortic wall inflammation. 1 Ruptured AAA is one of the leading causes of death among elderly men. 2 No pharmacological treatments for AAA are currently available, and despite the current progress of endovascular or invasive surgical options, tools to predict AAA rupture or delay its progression are still lacking. 3 Inflammation is a key feature of AAA onset as demonstrated by extensive medial and adventitial inflammatory cell infiltration into the vessel wall. 4 In human aneurysmal samples, macrophages are the main population observed in the arterial wall. 5 Macrophages are a major source of proteolytic enzymes, such as matrix metalloproteinases, that compromise the integrity of the vessel wall by degrading the extracellular matrix. 6, 7 The use of mouse models has highlighted the crucial role of macrophages in AAA. Studies have described early detection of macrophages in the abdominal aorta and emphasized their active role in AAA development. 8 Although no direct evidence has been provided to date, it has been suggested that macrophages present in the aneurysm wall could derive from circulating monocytes. 9 Monocyte/macrophage depletion using clodronate liposomes and genetic or pharmacological inhibition of chemokines involved in monocyte recruitment, including C-C chemokine receptor 2 (CCR2)/C-C chemokine ligand 2 or CX3C chemokine receptor 1 (CX3CR1), reduced the severity of aneurysm in mice. [10] [11] [12] Phenotypic characterization of monocyte subsets has led to the distinction of ≥2 main subsets with specific migratory behaviors and functions in mice. 13, 14 Studies have unraveled a remarkable multipotency of these cells in diverse inflammatory environments. [15] [16] [17] On the one hand, Classical (inflammatory) lymphocyte antigen 6C (Ly-6C) high monocytes rapidly infiltrate injured tissues and drive chronic inflammation in a CCR2dependent manner. 18, 19 On the other hand, nonclassical (resident) Ly-6C low monocytes express high levels of CX3CR1 and low levels of CCR2, patrol the endothelium of blood vessels, populate normal or inflammatory sites, and may contribute to wound healing. 15, [20] [21] [22] [23] [24] [25] However, in atherosclerosis, Ly-6C high and Ly-6C low monocytes are continuously recruited to the plaque using distinct chemokine receptor axes, [26] [27] [28] even though Ly-6C high monocyte infiltration dominates over Ly-6C low counterparts and gives rise to a large amount of plaque macrophages. 29 Blockade of monocyte recruitment has been shown to promote plaque regression. 30 Selective mobilization and trafficking patterns of the 2 monocyte subsets could depend on initial inflammatory triggers. For instance, Ly-6C high and Ly-6C low monocytes are sequentially recruited to the heart, soon after myocardial infarction. Although monocytes are mainly mobilized from the bone marrow (BM), recent studies have shed light on alternative mechanisms by which monocytes are rapidly deployed from the spleen in an angiotensin II-dependent manner. 31 Hence, identifying the mechanisms governing monocyte deployment might help understand their specific roles.
The purpose of this study was to investigate the trafficking pattern of the 2 monocyte subsets in response to angiotensin II (AngII) and identify their role in AAA expansion. Here, we used a mouse model of inflammatory AAA, in which AngII is infused into Apoe −/− male mice over a 28-day time course. We show that AngII induces early and transient mobilization of splenic but not BM-derived Ly-6C high and Ly-6C low monocytes. Splenectomy, B-cell depletion, or total lymphocyte deficiency impair the mobilization of splenic monocyte subsets and significantly protect from AAA development in mice.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Angiotensin II and Hypercholesterolemia Promote Monocyte-Derived Macrophage Accumulation in the Abdominal Aorta of Apoe −/− Mice
We investigated whether macrophages accumulating in the aneurysm wall derived from circulating monocytes. We conducted BM transplantation experiments, taking advantage of the congenic markers cluster of differentiation (CD) 45.1 and CD45.2.
The incidence of experimental AAA is augmented in Apoe −/− when compared with wild-type (WT) mice after AngII infusion, regardless of the increase in blood pressure. 32, 33 We first examined the effects of Apoe genotype, both in the vascular and in the medullar compartments, in triggering aortic macrophage accumulation in response to AngII. After lethal irradiation, Apoe −/− or WT CD45.2 mice were transplanted with Apoe −/− or WT CD45.1 BM and allowed to recover for 5 weeks. Reconstituted mice were then infused with AngII for 4 weeks to promote macrophage accumulation in the abdominal aorta ( Figure 1A ). Blood pressure was similar in all groups ( Figure IA in the online-only Data Supplement). Remarkably, transplantation of Apoe −/− BM into WT mice or WT BM into Apoe −/− mice led to a significant reduction in the amount of accumulating aortic macrophages along with a decrease to a similar extent of plasma cholesterol levels and circulating monocyte numbers ( Figure 1B ) when compared with Apoe −/− mice transplanted with Apoe −/− BM. We also found a positive correlation between the number of monocytes in circulation and the accumulation of macrophages in the abdominal aorta ( Figure IB in the online-only Data Supplement). Collectively, these findings point to an important role of hypercholesterolemia and monocytosis in promoting maximal macrophage accumulation in the abdominal aorta in response to AngII infusion.
Then, using the CD45.1 and CD45.2 markers, we analyzed in each condition whether accumulating macrophages derived from circulating monocytes. Chimerism in blood, BM, and spleen was determined at the end of the experiment and showed that <5% of circulating leukocytes were of CD45.2 origin, confirming an optimal reconstitution by CD45.1 donor-derived hematopoietic cells. Flow cytometry analysis revealed that in the 3 groups, independently of the experimental condition, >95% of the accumulating leukocytes in the abdominal aorta presented a CD45.1 medullar-associated signature ( Figure 1C ). This chimerism paralleled blood chimerism ( Figure IC in the online-only Data Supplement). Detailed analysis of aortic macrophages pointed out their exclusive CD11b + F4/80 + CD45.1 + signature, characteristic of a monocyte-derived origin. In contrast, we did not identify any resident CD11b low F4/80 + macrophages ( Figure ID in the online-only Data Supplement). Taken together, these data demonstrate that macrophages accumulating in the abdominal aorta after AngII delivery directly derive from circulating monocytes.
Angiotensin II-Mediated Transient Increase in Peripheral Ly-6C high and Ly-6C low Monocytes Predicts AAA Incidence
Because we showed that AngII triggered the accumulation of monocytes in the abdominal aorta in the context of AAA, we investigated the modulation of monocyte subset levels in blood in response to AngII infusion. We profiled both monocyte subsets in the blood during 28 days of AngII treatment by flow cytometry (Figure 2A ). Ly-6C high monocytes peaked Ly-6C lymphocyte antigen 6C
WT wild-type at day 3 and waned by days 7 and 9 when compared with control mice infused with PBS. Ly-6C low monocyte levels also increased after 3 days of AngII but reached statistical significance only at day 7 ( Figure 2B ). Monocyte subsets decreased back to the PBS level after 14 days and remained stable until the end of treatment ( Figure IIA in the online-only Data Supplement), showing that early mobilization of monocyte subsets is transient and may account for early aortic macrophage accumulation during AngII delivery. As a note, 14 days of AngII delivery significantly increased the pool of monocytes in the BM and the spleen, despite no change in the blood ( Figure IIB in the online-only Data Supplement). Despite controlled experimental conditions, the heterogeneity in AAA lesion development reported previously 34 and observed in our hands prompted us to evaluate whether changes in blood monocyte levels could be an indicator of later aneurysm formation ( Figure 2C ). We found that in mice that did not develop AAA, monocyte levels remained stable over the course of the experiment and were comparable with monocyte levels observed in response to PBS. Interestingly, however, mice that developed aneurysm after 28 days of AngII showed a significant early and transient increase of Ly-6C high and Ly-6C low monocytes ( Figure 2D ). This was independent of total plasma cholesterol or blood pressure variations ( Figure  IIC in the online-only Data Supplement).
Ly-6C high Monocyte Recruitment in Abdominal Aorta Dominates Over Ly-6C low Monocytes During the Early Phase of AAA
The recruitment process of Ly-6C high and Ly-6C low monocytes to an inflamed tissue occurs, in part, through CCR2 and CX3CR1, respectively. 13, 35 To verify whether early monocyte subset mobilization was followed by their infiltration into the aortic wall of the abdominal aorta, we quantified CCR2 and CX3CR1 expressions in aortic cryosections after PBS or at days 3 and 7 of AngII infusion. CCR2 and CX3CR1 were barely detectable under PBS infusion, illustrating the low level of monocyte accumulation in the abdominal aorta in baseline conditions. In contrast, after AngII infusion, CCR2 staining showed a peak of accumulation at day 3 after AngII infusion, followed by a decrease at day 7. CX3CR1 staining also started to increase also at day 3, peaked at day 7 ( Figure 3A ) and remained stable at day 14 ( Figure IIIA in the online-only Data Supplement) These observations mirror the observed increase of monocyte subsets in blood and support our finding that both monocyte subsets enter the abdominal aorta at an early time point.
We next quantified monocyte subset recruitment to the abdominal aorta. To this end, we adapted a bead-labeling technique previously developed to label and quantify monocyte trafficking in the atherosclerotic plaque. 30 We first controlled the suitability of this technique to our model by verifying that passive infiltration of beads was low ( Figure IIIB in the online-only Data Supplement). We then labeled Ly-6C high and Ly-6C low monocytes separately in 2 sets of experiments and quantified their recruitment in the abdominal aorta by immunofluorescence. Bead injection preferentially labels Ly-6C low over Ly-6C high monocytes. Specific labeling of Ly-6C high monocytes requires pretreatment with clodronate liposomes. 36 Compared with PBS, AngII infusion induced 5-fold increase of Ly-6C high classical monocyte recruitment at day 3 and 2-fold increase in Ly-6C low nonclassical monocytes at day 7 ( Figure 3B ). Taken together, our data show that Ly-6C high classical monocyte accumulation dominates within the first week of AngII delivery. Early accumulation of monocytes in the aortic wall was accompanied by an increase in local protease activity, which persisted over time. We did not find alteration of elastic lamellae at early time point ( Figure IIIC in the online-only Data Supplement), suggesting that monocyte/ macrophage contribution to extracellular matrix degradation in the abdominal aorta is a later event ( Figure 3C ).
Angiotensin II Promotes Ly-6C high and Ly-6C low Monocyte Mobilization From the Spleen, and Splenectomy Protects Against AAA Development
To evaluate the contribution of the spleen versus BM to the pool of infiltrating blood monocyte subsets after AAA induction, we infused mice with PBS or AngII for 3, 7, or 9 days. Remarkably, the increase of blood Ly-6C high classical monocytes at day 3 was mirrored by their decrease in the spleen and no significant change in the BM. The decrease of Ly-6C high monocytes in the splenic compartment was sustained at day 7. Ly-6C low monocytes significantly decreased in the spleen at day 3 of AngII infusion but not at a later time point ( Figure 4A and 4B) . Thus, the increase of circulating Ly-6C high and Ly-6C low monocytes at day 3 most likely resulted from their splenic release. These results indicate that both Ly6C high and Ly6C low monocytes are mobilized from the spleen as an early response to AngII.
Because the spleen seemed to be highly and rapidly responsive to AngII, we wondered whether monocyte release resulted from a mechanical contraction of the spleen in our model. We then administrated a bolus (10 μg) of AngII to WT mice and examined whether monocyte subsets had migrated out of the spleen by checking their numbers in the blood and spleen 1 hour after the AngII bolus. Our data show that monocyte content in blood remained unaltered after the AngII bolus, indicating that there was no release of monocytes as a rapid mechanical response of the spleen to AngII ( Figure IVA in the online-only Data Supplement).
On the basis of our assumption that the spleen provides the pool of monocyte subsets that initiates AAA formation, we hypothesized that splenectomy before AngII delivery would inhibit early monocyte subset mobilization into the blood and protect against AAA. Splenectomized or sham-operated mice were infused with AngII for ≤28 days with constant blood monitoring and AAA evaluation at sacrifice. As reported previously by others, 37 we noted an increase of blood monocytes rapidly after splenectomy. Monocyte numbers then reached a plateau after 1 week and returned to normal levels after 4 weeks ( Figure  IVB in the online-only Data Supplement). AAA was, therefore, induced 1 week after surgery, when monocytosis was stable. To monitor and compare the variation of blood monocytes in the sham and splenectomized groups, we systematically normalized circulating monocyte levels of each mouse to its own baseline level before AngII infusion. As expected, sham mice infused with AngII developed severe stages of aneurysm (classified as shown in Figure VA in the online-only Data Supplement). In contrast, splenectomized mice were significantly protected from AAA formation ( Figure 4C ). Despite elevated baseline monocytosis, spleen removal tended to decrease aortic macrophage accumulation in Apoe −/− mice ( Figure VB in the onlineonly Data Supplement). These results are in agreement with the literature. 38 Splenectomy-mediated protection from AngIIinduced AAA was not dependent on blood pressure ( Figure  VC in the online-only Data Supplement) or cholesterol levels (5.8±0.89 g/L in splenectomized mice versus 6.45±0.7 g/L in sham mice; ns).
Blood monitoring of these mice demonstrated that splenectomy significantly reduced AngII-mediated increase of Ly-6C high monocytes in blood at day 3, with a tendency toward Ly-6C low monocyte decrease ( Figure 4D ; Figure VC in the online-only Data Supplement for detailed cell numbers). Altogether, these data indicate that the splenic monocyte reservoir is mobilized after AngII infusion and contributes to AAA pathogenesis.
Lymphocyte Deficiency Limits AngII-Mediated Ly-6C high and Ly-6C low Monocyte Mobilization From the Spleen and Protects Against AAA Formation
We next investigated whether lymphocytes were involved in early splenic mobilization of Ly-6C high and Ly-6C low monocytes by generating Apoe −/− Rag2 −/− mice. At baseline, Apoe −/− Rag2 −/− mice showed comparable amounts of blood and spleen monocytes compared with Apoe −/− . In the BM, however, lymphocyte deficiency led to significant increase of monocyte numbers ( Figure VIA in the online-only Data Supplement). We then compared monocyte mobilization profiles in Apoe −/− and Apoe −/− Rag2 −/− mice in blood and spleen after 3 days of AngII infusion, each adjusted to their control baseline level. After 3 days of AngII, the absence of T and B lymphocytes impaired the expected increase of both Ly-6C high and Ly-6C low monocyte levels in the blood, when compared with control immunocompetent Apoe −/− mice ( Figure 5A ; Figure VIB in the online-only Data Supplement for detailed cell numbers). Inverse observations were noted in the spleen at day 3; the expected decrease of both Ly-6C high and Ly-6C low monocytes in the spleen of Apoe −/− mice was abrogated in Apoe −/− Rag2 −/− ( Figure 5A ; Figure VIC in the online-only Data Supplement for cell numbers). Therefore, lymphocyte deficiency recapitulates our findings on monocyte subset trafficking in splenectomized mice treated with AngII. By 28 days of AngII treatment, Apoe −/− Rag2 −/− mice also showed significant protection from AAA development ( Figure 5B ) together with a marked inhibition of macrophage accumulation in the abdominal aorta ( Figure 5C ). This was independent of plasma cholesterol level (6.07 g/l in Apoe −/− Rag2 −/− mice versus 5.73 g/l in Apoe −/− ). These findings demonstrate that T/B lymphocytes are involved in AngII-mediated monocyte subset mobilization from the spleen and contribute to AAA pathogenesis.
Because B cells have recently been shown to induce migration of classical monocytes to the infarcted myocardium, 39 we decided next to decipher the role of B and T lymphocytes in monocyte subset mobilization from the spleen. We specifically depleted either B or T cells in immunocompetent Apoe −/− mice. After an intravenous injection of depleting anti-CD4/ CD8, anti-CD20 or control isotype antibodies, mice were left for 4 days to ensure efficient T-or B-cell depletion ( Figure  VIIA in the online-only Data Supplement) [40] [41] [42] and were then infused with AngII for 3 days. Flow cytometry analysis of monocyte levels at day 3 revealed that B-cell depleted mice had significantly lower levels of circulating Ly-6C high and Ly-6C low monocytes than the T-cell depleted or control groups, indicating an impairment of mobilization of both monocyte subsets in the absence of B cells after AngII delivery ( Figure 5D ; Figure VIIB in the online-only Data Supplement). Collectively, our data show that B-cell but not T-cell total depletion recapitulates findings after spleen removal or total lymphocyte deficiency, leading us to hypothesize that B cells are responsible for monocyte trafficking after AngII infusion. 
Splenic B-Cell Depletion Prevents Early Mobilization of Ly-6C high and Ly-6C low and Protects Against AAA Formation
To analyze the role of splenic B cells during AngII-mediated monocyte mobilization specifically, we transferred total (isotype Ctr) or B-cell depleted (anti-CD20) splenocytes from Apoe −/− mice into recipient immunodeficient Apoe −/− Rag2 −/− mice.
After 2 weeks of recovery, mice were infused with AngII for 14 days ( Figure 6A ). Flow cytometry analysis showed that both Ly-6C high and Ly-6C low monocyte levels increased at day 3 after AngII infusion in Apoe −/− Rag2 −/− mice reconstituted with total Apoe −/− splenocytes, as observed previously in Apoe −/− mice, then returned to baseline at day 10. In contrast, Apoe −/− Rag2 −/− mice reconstituted with B-cell-depleted splenocytes failed to mobilize both monocyte subsets at day 3, confirming the role of B lymphocytes in monocyte mobilization ( Figure 6B ; Figure VIIC in the online-only Data Supplement for cell numbers). Analysis of total cholesterol levels showed no difference between the 2 groups (8.86±1.46 g/L in α-CD20 reconstituted ApoE −/− Rag2 −/− mice versus 7.98±2.27 g/L in α-Ctr reconstituted mice; ns).
The group reconstituted with total splenocytes not only regained monocyte mobilization at day 3 after AngII but also showed increased vascular matrix metalloproteinase activity ( Figure 6C ) and enhanced susceptibility to AAA in comparison with the group that received B-cell-depleted splenocytes ( Figure 6D ). Thus, splenic B lymphocytes promote rapid and transient monocyte mobilization from the splenic reservoir in response to AngII delivery and participate in AAA development in Apoe −/− mice.
Discussion
Monocyte trafficking in the setting of cardiovascular diseases has garnered considerable recent attention because more and more studies suggested new roles for distinct monocyte subsets in disease development and progression. 27, 29, [43] [44] [45] [46] In AAA, the presence of inflammatory infiltrates, and particularly monocytes/macrophages, has underscored the contribution and importance of immunoinflammatory responses in aneurysmal degeneration. Monocyte migration in response to AngII has been widely investigated through in vitro and in vivo experiments, 23, 31, 39, 47 but no study had examined the trafficking and recruitment of the monocyte subsets in the context of AAA. Here, we described the trafficking pattern of both Ly-6C high and Ly-6C low monocytes during AngII-induced AAA formation in Apoe −/− mice. We find that (1) AngII drives Ly-6C high and Ly-6C low monocyte mobilization from the spleen and recruitment to the abdominal aorta, (2) splenectomy or B-cell depletion abrogate mobilization of both monocyte subsets mobilization and protect from AAA development, (3) reconstitution of lymphocyte-deficient mice with total splenocytes but not with B-cell-depleted splenocytes restores monocyte subset mobilization and susceptibility to AAA.
Our data demonstrate that continuous infusion of AngII drives macrophage accumulation in the abdominal aorta in hypercholesterolemic mice through the recruitment of circulating monocytes. This extends previous findings, 9, 32 which showed that AngII infusion promoted AAA formation in parallel with the accumulation of macrophages in the abdominal aorta of Apoe −/− mice, independently of blood pressure levels. 33 Using BM transplantation experiments and CD45.1/.2 congenic markers, our findings rule out the possibility that macrophage accumulation mainly results from the proliferation of resident progenitors. However, other investigators 48, 49 have reported that either BM-derived or local progenitor cells may represent local vascular sources of inflammatory cells. Here, we cannot completely exclude the possibility that recruited BM-derived cells might have artificially replenished tissue-resident macrophages after possible experimental deletion through the irradiation process. Nevertheless, our results demonstrate that aortic macrophages accumulating in response to AngII ultimately derive from a circulating precursor but do not exclude a role for local proliferation of the recruited monocytes or other BM-derived cells.
In line with a previous study in the context of myocardial infarction showing the exit of both monocyte subsets from the spleen in response to AngII, 31 we observed at day 3 a simultaneous increase of both Ly-6C high and Ly-6C low monocytes in the blood along with their decrease in the spleen, suggesting that they were mobilized from the splenic reservoir. Ly-6C low monocytes reached their peak level in the blood at day 7 post AngII without a further decrease in the spleen, which could be accounted for by the conversion of Ly-6C high monocytes into Ly-6C low monocytes. [50] [51] [52] It is also possible that Ly-6C low monocytes were released from crawling on the vascular endothelium, 20 or raised independently from BM, 53 although this was not detectable in our analysis.
Differential expression of chemokine receptor profiles has received considerable attention as markers of monocyte subsets. In atherosclerosis and aneurysm, several chemokine receptors relevant to monocyte recruitment have been identified, including CCR2 and CX3CR1. 43 In various models of acute inflammation, CCR2 has been shown to drive the early accumulation of Ly-6C high monocytes, whereas CX3CR1 has been mostly implicated in trafficking and survival of Ly-6C low monocytes. On the basis of CCR2 and CX3CR1 expression in the abdominal aorta, we speculated that Ly-6C high monocytes accumulate in the aortic wall at day 3 followed by Ly-6C low monocytes at day 7, despite their initial increase in the blood at day 3. However, the recruitment of circulating Ly-6C low monocytes at day 7 as quantified by the bead-labeling technique was minimal. It is, therefore, unlikely that they contributed significantly to the accumulation of CX3CR1-positive cells in the abdominal aorta. These cells could derive from the differentiation of day-3-mobilized Ly-6C high monocytes into Ly-6C low macrophages as shown in a recent study 25, 54 or from local proliferation. In addition, our fluorescent tomography data showed that early accumulation of monocytes in the aortic wall was accompanied by an increase of protease activity in situ, suggesting a strong contribution of recruited monocytes to disease pathogenesis. Further investigation is required to address the mechanisms by which monocyte subsets contribute to aortic remodeling in the context of AngII-induced AAA.
A growing body of literature indicates that blood monocyte counts correlate with coronary disease development. 27, 55 As it has been shown by others, the number of Ly-6C high monocytes rapidly and dramatically increases in the circulation in response to acute injury or infection. 23, 56 Here, we found that early monocyte increase in the blood predicts the incidence of AAA formation in Apoe −/− mice. We also found that this increase was most likely explained by mobilization from the splenic monocyte reservoir. More intriguingly, our results strongly point to B cells as key actors in early monocyte mobilization and suggest direct communication between B cells and monocytes in the early response to AngII infusion. But B cells could also play a direct role in the aneurysmal pathogenesis or promote late macrophage accumulation in the AAA, for instance, through mediation of extramedullary hematopoiesis. This should be the subject of further exploration.
Our findings are in agreement with the recently described role of B lymphocytes in the recruitment of Ly-6C high monocytes in the heart and subsequent alteration of cardiac function after myocardial infarction in C57Bl6 mice. 39 This highlights the importance of further research to address the effect of AngII on B-cell-monocyte interaction and identify the types of B cells involved in orchestrating AAA inflammation.
In conclusion, this study provides novel mechanistic insights on the early events involved in AngII-induced AAA formation. It highlights the role of the splenic monocyte reservoir in this process and identifies an intriguing role for B lymphocytes in mediating AngII-induced early and transient mobilization of splenic monocytes. Further understanding of the molecular mechanisms that underlie such interactions is likely to lead to the identification of effective therapeutic targets.
